{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T05:51:32Z","timestamp":1682488292821},"reference-count":44,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":5906,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,7]]},"DOI":"10.1111\/j.1600-0404.1999.tb00722.x","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T21:16:20Z","timestamp":1233263780000},"page":"42-52","source":"Crossref","is-referenced-by-count":6,"title":["NMSP binding to dopamine and serotonin receptors in MPTP-induced parkinsonism: relation to dopa therapy"],"prefix":"10.1155","volume":"100","author":[{"given":"K.","family":"Borbely","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. F.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Stanley","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cimming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gjedde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Chiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1212\/WNL.37.10.1575","article-title":"MPTP-induced up-regulation of in vivo dopaminergic radioligand-receptor binding in humans","volume":"37","author":"Perlmutter","year":"1987","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB2","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/WNL.44.7.1325","article-title":"[11C]Raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors","volume":"44","author":"Antonini","year":"1994","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/syn.890210107","article-title":"Effect of L-dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum, quantified using PET","volume":"21","author":"Hume","year":"1995","journal-title":"Synapse"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s007020050063","article-title":"Modulatory effects of L-dopa on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET","volume":"105","author":"Opacka-Juffry","year":"1998","journal-title":"J Neural Transm"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3940(98)00198-0","article-title":"Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice","volume":"245","author":"Rozas","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01245250","article-title":"Attenuation of MPTP-induced dopaminergic neurotoxicity by a serotonin uptake blocker","volume":"71","author":"Brooks","year":"1988","journal-title":"J Neural Transm"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0006-8993(96)01227-9","article-title":"The effect of unilateral neurotoxic lesions to serotonin fibres in the medial forebrain bundle on the metabolism of [3H]dopa in the telencephalon of the living rat","volume":"747","author":"Cumming","year":"1997","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/jcbfm.1986.27","article-title":"Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands","volume":"6","author":"Wong","year":"1986","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB9","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJM198505303122203","article-title":"The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"312","author":"Burns","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB10","first-page":"19","article-title":"The purely neuroleptic effect and its relation to the \u201cneuroleptic threshold","volume":"78","author":"Haase","year":"1978","journal-title":"Acta Psychiatr Belg"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB11","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1109\/TNS.1983.4332346","article-title":"Performance evaluation and calibration of the Neuro-PET scanner","volume":"30","author":"Sank","year":"1983","journal-title":"IEEE Trans Nucl Sci"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB12","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1212\/WNL.51.4.1075","article-title":"A levodopa kinetic-dynamic study of the rate of progression in Parkinson's disease","volume":"51","author":"Contin","year":"1998","journal-title":"Neurology"},{"issue":"Part 3","key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB13","doi-asserted-by":"crossref","first-page":"A23","DOI":"10.1016\/S1053-8119(18)31892-5","article-title":"Reference region model of irreversible ligand binding","volume":"7","author":"Gjedde","year":"1998","journal-title":"NeuroImage"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB14","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1126\/science.2878495","article-title":"Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics","volume":"234","author":"Wong","year":"1986","journal-title":"Science"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/archpsyc.1990.01810150013003","article-title":"D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride","volume":"47","author":"Faroe","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-1781(93)90063-M","article-title":"Dopamine D2 receptor density estimates in schizophrenia: A positron emission tomography study with 11C-N-methylspiper-one","volume":"49","author":"Tune","year":"1993","journal-title":"Psychiatry Res"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.6147018","article-title":"Bimodal distribution of dopamine receptor densities in brain of schizophrenics","volume":"225","author":"Seeman","year":"1984","journal-title":"Science"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0024-3205(78)90166-2","article-title":"3H-Spiperone binding in normal and schizophrenic post-mortem human brain","volume":"23","author":"Mackay","year":"1978","journal-title":"Life Sci"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0006-8993(89)90031-0","article-title":"Dopamine receptors in human brain: autoradiographic distribution of DI and D2 sites in Parkinson syndrome of different etiology","volume":"483","author":"Cortes","year":"1989","journal-title":"Brain Res"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(84)90238-3","article-title":"[3H]Spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy","volume":"99","author":"Bokobza","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ana.410190510","article-title":"Dopamine D2 receptor density remains constant in treated Parkinson's disease","volume":"19","author":"Guttman","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/273059a0","article-title":"Receptor basis for dopaminergic supersensitivity in Parkinson's disease","volume":"278","author":"Lee","year":"1978","journal-title":"Nature (Lond.)"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0022-510X(79)90021-2","article-title":"Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in Shy-Drager syndrome and Parkinson's disease","volume":"43","author":"Quik","year":"1979","journal-title":"J Neurol Sci"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0024-3205(77)90514-8","article-title":"Neurotransmitter receptor alterations in Parkinson's disease","volume":"21","author":"Reisine","year":"1977","journal-title":"Life Sci"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01664007","article-title":"Dopamine receptors in the parkinsonian brain","volume":"51","author":"Rinne","year":"1981","journal-title":"J Neurol Transm"},{"issue":"Suppl.","key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB26","first-page":"279","article-title":"Brain receptor changes in Parkinson's disease in relation to the disease process and treatment","volume":"16","author":"Rinne","year":"1983","journal-title":"J Neurol Transm"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0022-510X(87)90158-4","article-title":"Tracing of dopamine receptors in hemiparkin-sonism with positron emission tomography (PET)","volume":"80","author":"Rutgers","year":"1987","journal-title":"J Neurol Sci"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00002826-198409000-00006","article-title":"Dopamine receptors: Effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease","volume":"7","author":"Schneider","year":"1984","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB29","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1212\/WNL.34.9.1208","article-title":"Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum","volume":"34","author":"Reches","year":"1984","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB30","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/0024-3205(80)90083-1","article-title":"Effect on long-term L-dopa administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats","volume":"27","author":"Suga","year":"1980","journal-title":"Life Sci"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB31","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1021\/jm00025a013","article-title":"l-Phenyl-3-(aminomethyl)pyrroles as potential antipsychotic agents. Synthesis and dopamine receptor binding","volume":"38","author":"Thurkauf","year":"1995","journal-title":"J Med Chem"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/syn.890200406","article-title":"D3 and D2 dopamine receptors: Visualization of cellular expression patterns in motor and limbic structures","volume":"20","author":"Larson","year":"1995","journal-title":"Synapse"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB33","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1021\/jm00022a019","article-title":"l-alpha,25-dihydroxyvitamin D3 analogs featuring aromatic and heteroaromatic rings: Design, synthesis and preliminary biological testing","volume":"38","author":"Posner","year":"1995","journal-title":"J Med Chem"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02311185","article-title":"D2 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs","volume":"120","author":"Roth","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB35","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1471-4159.1985.tb12891.x","article-title":"Comparison of three 18F labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography","volume":"44","author":"Arnett","year":"1985","journal-title":"J Neurochem"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB36","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0024-3205(85)90041-4","article-title":"18F-N-methylspiroperidol: the radioligand of choice for PET-studies of the dopamine receptors in human brain","volume":"36","author":"Arnett","year":"1985","journal-title":"Life Sci"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ana.410150302","article-title":"A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography","volume":"15","author":"Mintun","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB38","first-page":"3","article-title":"Clinical experience with spiperone","volume":"10","author":"Nomura","year":"1973","journal-title":"Clin Med"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004728-198501000-00024","article-title":"Atlas of dopamine receptor images (PET) of the human brain","volume":"9","author":"Inoue","year":"1985","journal-title":"J Comput Assist Tomogr"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/jcbfm.1986.28","article-title":"Quantification of neuroreceptors in the living human brain. II. Inhibition studies of receptor density and affinity","volume":"6","author":"Wong","year":"1986","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0404.1987.tb07900.x","article-title":"Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone","volume":"75","author":"Hagglund","year":"1987","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01245132","article-title":"Striatal binding of 11C studied with positron emission tomography in patients with persistent tardive dyskinesia: no evidence for altered dopamine D2 receptor binding","volume":"79","author":"Andersson","year":"1990","journal-title":"J Neural Transm"},{"key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB43","first-page":"1008","article-title":"Simultaneous in vivo measurement of human dopamine and serotonin Bmax using high and low specific activity (C-ll)NMSP and a unified estimation procedure","volume":"32","author":"Wong","year":"1991","journal-title":"J Nucl Med"},{"issue":"Part 3","key":"10.1111\/j.1600-0404.1999.tb00722.x-BIB44","first-page":"A44","article-title":"Psychotic propensity associated with fourfold elevated dopamine binding to D2-like receptors in caudate nucleus","volume":"5","author":"Gjedde","year":"1997","journal-title":"Neurolmage"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.1999.tb00722.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.1999.tb00722.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:41:46Z","timestamp":1671540106000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.1999.tb00722.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.1999.tb00722.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"value":"0001-6314","type":"print"},{"value":"1600-0404","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,7]]}}}